Literature DB >> 26718775

Hypoxia inducible factor-1 mediates upregulation of urokinase-type plasminogen activator receptor gene transcription during hypoxia in cervical cancer cells.

Hirotaka Nishi1, Toru Sasaki1, Yuzo Nagamitsu1, Fumitoshi Terauchi1, Takeshi Nagai2, Toshitaka Nagao2, Keiichi Isaka1.   

Abstract

Hypoxia occurs during development of cervical cancer and is considered to correlate with its invasion. Hypoxia mediates tumor cells to have more invasive property in a variety of cancers. Urokinase plasminogen activator receptor (uPAR) which mediates invasion is considered to be induced by hypoxia. We sought to determine the regulators of uPAR expression during hypoxia in cervical cancer. We showed that cervical cancer cell lines, CaSki and CA, were more invasive under hypoxic condition (1% O2) than under normoxic condition (20% O2) by invasion assays. Using western blot analysis, hypoxia enhanced the endogenous hypoxia-inducible factor (HIF)-1α and uPAR protein expression. uPAR mRNA level was also upregulated by hypoxia using real-time RT-PCR. Overexpression of HIF-1α which is induced by hypoxia activated the transcriptional activity of the uPAR promoter by luciferase assays. HIF-1 protein bound the putative HIF-1 response element on the uPAR promoter using electrophoretic mobility shift analysis, and additional luciferase assays show that this is essential for uPAR transactivation by HIF-1. HIF-1 overexpression enhanced the endogenous uPAR expression and introduction of siRNA for HIF-1α diminishes uPAR expression during hypoxia. These results indicate the upregulation of uPAR by hypoxia in cervical cancer cells is mediated through HIF-1. In cervical cancer tissues, we also demonstrated that uPAR protein expression was detected in cervical cancer but not in normal cervix or cervical intraepithelial neoplasia (CIN) by immunohistopathological staining. Our results provide evidence that regulation of uPAR expression by HIF-1 represents a mechanism for cervical cancer invasion during hypoxia.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26718775     DOI: 10.3892/or.2015.4449

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  7 in total

1.  TCF7L2 promotes anoikis resistance and metastasis of gastric cancer by transcriptionally activating PLAUR.

Authors:  Tao Zhang; Bofang Wang; Fei Su; Baohong Gu; Lin Xiang; Lei Gao; Peng Zheng; Xue-Mei Li; Hao Chen
Journal:  Int J Biol Sci       Date:  2022-07-11       Impact factor: 10.750

2.  Do coagulation or fibrinolysis reflect the disease condition in patients with soft tissue sarcoma?

Authors:  Kunihiro Asanuma; Tomoki Nakamura; Takayuki Okamoto; Tomohito Hagi; Kouji Kita; Koichi Nakamura; Yumi Matsuyama; Keisuke Yoshida; Yumiko Asanuma; Akihiro Sudo
Journal:  BMC Cancer       Date:  2022-10-18       Impact factor: 4.638

3.  TLR4 promotes the expression of HIF-1α by triggering reactive oxygen species in cervical cancer cells in vitro-implications for therapeutic intervention.

Authors:  Xiao Yang; Gan Tao Chen; Yan Qing Wang; Shu Xian; Li Zhang; Shao Ming Zhu; Feng Pan; Yan Xiang Cheng
Journal:  Mol Med Rep       Date:  2017-11-20       Impact factor: 2.952

Review 4.  The uPAR System as a Potential Therapeutic Target in the Diseased Eye.

Authors:  Maurizio Cammalleri; Massimo Dal Monte; Vincenzo Pavone; Mario De Rosa; Dario Rusciano; Paola Bagnoli
Journal:  Cells       Date:  2019-08-18       Impact factor: 6.600

5.  The urokinase-type plasminogen activator system as drug target in retinitis pigmentosa: New pre-clinical evidence in the rd10 mouse model.

Authors:  Maurizio Cammalleri; Massimo Dal Monte; Filippo Locri; Valeria Pecci; Mario De Rosa; Vincenzo Pavone; Paola Bagnoli
Journal:  J Cell Mol Med       Date:  2019-06-28       Impact factor: 5.310

Review 6.  HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons.

Authors:  Andrey A Poloznikov; Stepan A Nersisyan; Dmitry M Hushpulian; Eliot H Kazakov; Alexander G Tonevitsky; Sergey V Kazakov; Valery I Vechorko; Sergey V Nikulin; Julia A Makarova; Irina G Gazaryan
Journal:  Front Pharmacol       Date:  2021-01-29       Impact factor: 5.810

Review 7.  Hypoxia-dependent drivers of melanoma progression.

Authors:  Simona D'Aguanno; Fabiana Mallone; Donatella Del Bufalo; Antonietta Moramarco; Marco Marenco
Journal:  J Exp Clin Cancer Res       Date:  2021-05-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.